27 Recruiting Studies Using Ivonescimab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ivonescimab
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
📍 City of Hope Medical Center — Duarte, California
Advanced Microsatellite Stable Colorectal Carcinoma
View Study & Checklist ➔A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
📍 UT MD Anderson Cancer Center — Houston, Texas
Phase II
View Study & Checklist ➔STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)
📍 MD Anderson Cancer Center — Houston, Texas
Phase II
View Study & Checklist ➔Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Cutaneous Squamous Cell Carcinoma
View Study & Checklist ➔A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Metastatic Endocrine Refractory
View Study & Checklist ➔A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Ivonescimab in People With Endometrial and Cervical Cancers
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Endometrial Cancer
View Study & Checklist ➔Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
📍 University of Miami — Miami, Florida
Extensive Stage Lung Small Cell Cancer
View Study & Checklist ➔Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Metastatic Colorectal Cancer
View Study & Checklist ➔I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Glioblastoma
View Study & Checklist ➔A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Non-Small Cell Lung Cancer
View Study & Checklist ➔Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
TNBC
View Study & Checklist ➔Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Ivonescimab
View Study & Checklist ➔A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Ivonescimab in People With Leiomyosarcoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Leiomyosarcoma
View Study & Checklist ➔Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
📍 Banner University Medical Center — Phoenix, Arizona
Non-Small Cell Lung Cancer
View Study & Checklist ➔Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
📍 Clinical Study Site — Chandler, Arizona
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Non-Small Cell Lung Cancer
View Study & Checklist ➔Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
📍 UT MD Anderson — Houston, Texas
Cutaneous Angiosarcoma
View Study & Checklist ➔Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Advanced Solid Tumors
View Study & Checklist ➔Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
📍 University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan
Advanced Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
📍 City of Hope Medical Center — Duarte, California
Localized Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
📍 UCLA — Santa Monica, California
Stomach Cancer Stage IV
View Study & Checklist ➔Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
📍 Massachusetts General Hospital — Boston, Massachusetts
Lung Cancer (NSCLC)
View Study & Checklist ➔Ivonescimab for the Treatment of Thymic Cancer
📍 University of California at Davis (UCD) — Davis, California
Thymus Carcinoma
View Study & Checklist ➔A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
📍 Brigham and Women's Hospital — Boston, Massachusetts
Salivary Gland Cancer
View Study & Checklist ➔